ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. MacroGenics Gets $40m Up Front For St
ScripThe first Phase III data for Grunenthal GMBH ’s analgesic cebranopadol in cancer pain show it was non-inferior and on the main measure even superior to prolonged-release morphine sulfate, with comp
HBW InsightAnother Coca-Cola exec pops up at NBTY [NBTY Inc.] adds another former Coca-Cola Co. executive to its management as Brian Wynne becomes Americas markets head, working with President and CEO Steve
Pink SheetAnother Coca-Cola exec pops up at NBTY [NBTY Inc.] adds another former Coca-Cola Co. executive to its management as Brian Wynne becomes Americas markets head, working with President and CEO Steve